Tradestie Institutional Equity Comparison Engine
VIVS vs ASMB โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ASMB Overall Edge
ASMB Captures Institutional Edge (4โ0 Pillars ยท 6โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Assembly Biosciences, Inc (ASMB) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, VIVS trades at N/M Forward P/E with -10117.0% operating margin (-51.4% YoY revenue) versus ASMB at N/M Forward P/E and -31.8% operating margin (-72.6% YoY). In options structure, VIVS sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against ASMB sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
ASMB
VIVS N/M vs ASMB N/M Fwd P/E
Growth & Margin Winner
ASMB
Op Margin -10117.0% vs -31.8% ยท YoY -51.4% vs -72.6%
Momentum & Technical Winner
ASMB
1Y -87.0% vs -37.3% ยท 52W Pos 5% vs 16%
Options & Structure Winner
ASMB
BREAKDOWN (N/A IV) vs UNCLASSIFIED (100th %ile IV)
VIVS
NASDAQ
VivoSim Labs, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$0.29
+142.92% 1D
Market Cap
$2.4M
1M Return
+64.69%
1Y Return
-86.99%
Forward P/E
N/M
Unified AI Score
36.8 / 100
SELL
Tech 5.0
Fund 38.0
Flow 50.0
Mom 50.0
ASMB
NASDAQ
Assembly Biosciences, Inc
Pharmaceutical Preparations
$22.50
+0.49% 1D
Market Cap
$464.6M
1M Return
+9.97%
1Y Return
-37.31%
Forward P/E
N/M
Unified AI Score
31.0 / 100
SELL
Tech 3.0
Fund 37.0
Flow 50.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
VIVS -86.99%
ASMB -37.31%
Spread: +49.68 pp (ASMB Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
VIVS TTM Op. Margin: -10117.0%
ASMB TTM Op. Margin: -31.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on VIVS vs ASMB. Trailing 12-month operating profitability (VIVS -10117.0% vs ASMB -31.8%) and valuation multiples (VIVS N/M vs ASMB N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | VIVS | ASMB | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $2.4M | $464.6M | Larger Scale | ASMB |
| Trailing P/E Ratio Valuation | N/M | 30.2x | Lower Multiple | ASMB |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -51.4% | -72.6% | Higher Growth | VIVS |
| Operating Margin (TTM) Profitability | -10117.0% | -31.8% | Higher Margin | ASMB |
| Net Profit Margin Profitability | 0.0% | -16.6% | Higher Margin | VIVS |
| Return on Equity (ROE) Capital Efficiency | -343.1% | -4.6% | Higher ROE | ASMB |
| 52-Week Range Position Momentum | 5% ($0โ$3) | 16% ($19โ$40) | Stronger Trend | ASMB |
| Beta / 30D Volatility Risk Regime | 0.83ฮฒ ยท 480% Vol | 0.99ฮฒ ยท 57% Vol | Lower Realized Risk | ASMB |
| Unified Institutional Score Composite Signal | 36.8 / 100 (SELL) | 31.0 / 100 (SELL) | Higher Composite | VIVS |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full VIVS vs ASMB Buy Guide
VIVS
BREAKDOWN
73d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
ASMB
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
100th %ile
IV Regime
Extreme (>80th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither VIVS nor ASMB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.